Particle.news

Download on the App Store

Mexico Names 33 Drug Suppliers Over Contract Breaches as Second Rutas de la Salud Distribution Begins

Officials set an end-of-September compliance deadline with sanctions for vendors that still have not delivered.

Overview

  • Health authorities reported IMSS at roughly 97% availability, ISSSTE at similar levels, and IMSS‑Bienestar at about 92% with 96% in oncology medicines.
  • The second monthly kit deployment launched on Sept. 22 to supply 8,342 centers with 9,632 prepacked sets covering 147 essential drugs, with routes running through Sept. 26.
  • The government detailed shortfalls for key contractors, including Bioxintegral Servicios at 100% non‑delivery, Productos Farmacéuticos at 88.6%, Serral at 83.7%, and Puerta del Sol Capital with 14.1 million pieces undelivered of 21.3 million.
  • Oncology gaps were flagged as sensitive, with firms such as Accord Farma and Zurich Pharma cited for delays, and direct shipping from the Megafarmacia to 56 IMSS‑Bienestar cancer centers continuing.
  • President Claudia Sheinbaum said the Anticorruption Secretariat is arranging substitutions at the same prices, as August receipts reached about 186 million pieces, 138% higher than May.